The recent characterization of human homologues of Toll may be the missing link for the transduction events leading to NF-B activity and proinflammatory gene transcription during innate immune response. Indeed, CD14 is not thought to participate directly in the cell signaling, but rather one or more of the mammalian Toll-like receptors (TLRs) acts in concert with the lipopolysaccharide (LPS) receptor to discriminate between microbial pathogens or their products and initiate transmembrane signaling. Mammalian cells may express as many as 10 distinct TLRs, although the importance of TLR4 in response to gramnegative bacteria and LPS is now supported by the fact that TLR4-mutated mice are LPS resistant. We investigated the expression of TLR4 across the rat brain under basal conditions and in response to systemic LPS and IL-1␤ injection. We first cloned the rat TLR4 cDNA via RNA isolation and polymerase chain reaction (PCR) amplification with a proofreading polymerase. Total RNA was isolated from the rat liver tissue using TriReagent and reverse transcribed into cDNA using Superscript II reverse transcriptase and an oligonucleotide primer with a degenerate 3 end of sequence 5-T12(GAC)N-3. Positive hybridization signal was found in the leptomeninges, choroid plexus (chp), subfornical organ, organum vasculosum of the lamina terminalis, median eminence, and area postrema. Scattered small cells also displayed a convincing hybridization signal within the brain parenchyma. 
Host organisms detect the presence of infection by recognizing specific elements produced by micro-organisms such as gram-negative bacteria, gram-positive bacteria, and mannans of fungi (1) . These elements are called the pathogen-associated molecular patterns (PAMPs), which are recognized by specific cells of the immune system as innate mechanisms to mount a rapid response to bacterial infection. The endotoxin lipopolysaccharide (LPS) is a major component of the outer membranes of gram-negative bacteria, which is the best-characterized example of innate recognition associated with a robust inflammatory response by phagocytic cells (2) . Secretion of cytokines by circulating monocytes/neutrophils and tissue macrophages by LPS requires a series of mechanisms in cascade, the first step being binding of the endotoxin with the serum proteins LPS binding protein (LBP) or septins. The newly formed complex may then activate different populations of cells in binding to its receptor in two forms: the membrane CD14 (mCD14) and soluble CD14 (sCD14) (3) .
mCD14 is present at the surface of myeloid cells and acts as a glycosylphosphatidylinositol (GPI) -anchored membrane glycoprotein, whereas sCD14 lacks the GPI properties but can bind LPS to activate cells devoid of mCD14, such as endothelial cells (4) . Until recently, the exact mechanisms involved in the activation of the proinflammatory signal transduction pathways after binding between the LBP-LPS complex and the GPIanchored mCD14 were unknown. Indeed, studies in CD14-deficient mice suggested the existence of a coreceptor to mediate LPS-induced nuclear factor kappa B (NF-B) activity and cytokine gene transcription (5, 6) . The recent characterization of human homologues of Toll may be the missing link for the transduction events leading to NF-B activity and cytokine production in response to the bacterial cell wall components. A large family of Toll-like receptors (TLRs) has already been characterized that share similar extracellular and cytoplasmic domains (1) . The extracellular domains include 18 -31 leucine-rich repeats, whereas the cytoplasmic domains are similar to the cytoplasmic portion of the interleukin 1 (IL-1) receptor and is named the Toll/IL-1-receptor homologous region (1, 7) . Distinct TLRs have now been proposed as the key molecules to recognize quite selectively one of the major PAMPs produced by either gram-negative or gram-positive bacteria. The data that mutation of the mouse Lps locus abolishes the LPS response and that Lps encodes the TLR4 provided the first evidence that this particular receptor may play a key role in the innate immune response to gram-negative bacteria (for a review, see ref 8) . Further supporting this concept are the TLR4-deficient mice, which are unresponsive to LPS, whereas TLR2-deficient mice exhibit a normal inflammatory response to the endotoxin (9). These results demonstrate that whereas TLR2 makes no contribution to LPS signaling, TLR4 is critical to recognize the PAMP produced by gram-negative bacterial cell wall components.
It is not yet known how LBP, CD14, and TLR4 interact to function as the LPS signal transducer leading to activation of NF-B and mitogen-activated protein kinases. It is possible that CD14 acts as the principal LPS binding protein on the surface of monocytic cells and the newly formed complex reaches adjacent TLR4 receptors that transduce the LPS signal via the general adaptor protein MyD88 (8, 10) . These events may also take place in the brain because CD14 mRNA is constitutively expressed in the circumventricular organs (CVOs), brain regions that contain a rich vascular plexus with specialized arrangements of the blood vessels (11) . The tight junctions normally present between the endothelial cells are shifted in part to the ventricular surface and partly to the boundary between the CVOs and the adjacent structures, explaining the diffusion of large molecules into the perivascular region (12) . Circulating LPS causes a rapid increase in CD14 transcription in these leaky structures, whereas a delayed response can be found in parenchymal cells located in the anatomical boundaries of the CVOs and thereafter in microglia across the brain parenchyma (11, 13) .
These results strongly suggest that the endotoxin first reaches organs devoid of the blood-brain barrier to induce the transcription of its own receptor and thereafter increases CD14 biosynthesis within parenchymal structures surrounding the CVOs and then the entire brain of severely challenged animals. TLR4 is likely to play a key role in the LPS signaling and the innate immune response that is triggered in a very wellorganized manner from specific structures of the brain during endotoxemia (13, 14) . The purpose of this study was therefore to investigate whether TLR4 is present in the brain and determine the fine cellular distribution and regulation of the gene encoding TLR4 in the rat brain under basal and immune-challenged conditions.
MATERIALS AND METHODS

Animals
Adult male Sprague-Dawley rats (ϳ230 -260 g b.w.) were acclimated to standard laboratory conditions (14 h light, 10 h dark cycle; lights on at 0600 and off at 2000) with free access to rat chow and water. Each rat was used only once for experimentation and all protocols were approved by the Laval University's Animal Welfare Committee. Sixty-four rats were assigned to different protocols each corresponding to different treatments, which were further subdivided into different postinjection times (15 min to 24 h, depending on the challenge). Paired vehicle-treated rats were also killed at corresponding times after the injection.
Surgeries
Rats were anesthetized with an intraperitoneal injection of a mixture (1 ml/kg b.w.) of ketamine hydrochloride (91 mg/ ml) and xylazine (9 mg/ml) and implanted with a catheter into the jugular vein. Catheters were made from a piece of silastic tubing (silastic medical grade tubing: ID 0.020 in, OD 0.037 in; Dow Corning, Midland, Mich.) connected to an intramedic polyethylene tubing (PE-50, ID 0.023 in, OD 0.038 in, Caly Adams, Becton Dickinson, Rutherford, N.J.). Outlets of cannulas were placed at the level of the neck, and rats were housed individually in plastic cages for a recuperation period of 3-5 days.
Experimental protocols
On the day of the experiment (ϳ0830 in the morning), the outlet portion of the intravenous (i.v.) catheter was fixed to a truncated 22 gauge needle, which was attached to a PE-50 tubing. These connectors were then fixed to a 1 cc syringe and rats were placed individually in a quiet room for at least 2 h before the injections, which allows injections without disturbing the animals and induction of genes that may be activated after the stress of handling. LPS (40 -100 g/kg; from Escherichia coli, Serotype 055:B5, Sigma, L-2880, lot #127H4097), recombinant rat IL-1␤ (1.8 g/kg; kindly provided by Dr. R. Hart, The State University of New-Jersey Rutgers, Newark, N.J.), or the vehicle solution (200 l of sterile pyrogen-free saline) was injected i.v. through the right jugular vein.
At different times after the systemic injections (from 15 min to 24 h, depending on the challenge), animals were deeply anesthetized via an i.v. injection of a mixture of ketamine hydrochloride and xylazine, then rapidly perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde in 0.1 M borax buffer (pH 9.5 at 4°C). Brains were removed swiftly from the skulls, postfixed for 2 to 8 days, and placed in a solution containing 10% sucrose diluted in 4% paraformaldehyde-borax buffer overnight at 4°C. The frozen brains were mounted on a microtome (Reichert-Jung, Cambridge Instruments Company, Deerfield, Ill.) and cut into 30 m coronal sections from the olfactory bulb to the end of the medulla. The slices were collected in a cold cryoprotectant solution (0.05M sodium phosphate buffer, pH 7.3, 30% ethylene glycol, 20% glycerol) and stored at Ϫ20°C.
In situ hybridization histochemistry
Hybridization histochemical localization of TLR4, CD14, and IB␣ mRNA was carried out on every sixth section of the whole rostro-caudal extent of each brain using 35 S-labeled cRNA probes. All solutions were treated with diethylpyrocarbonate (Depc) and sterilized to prevent RNA degradation. Tissue sections mounted onto poly-L-lysine-coated slides were desiccated overnight under vacuum, fixed in 4% paraformaldehyde for 30 min, and digested with proteinase K (10 g/ml in 0.1 M tris HCl, pH 8.0, and 50 mM EDTA, pH 8.0, at 37°C for 25 min). Brain sections were rinsed in sterile Depc water, followed by a solution of 0.1 M triethanolamine (TEA, pH 8.0), acetylated in 0.25% acetic anhydride in 0.1 M TEA, and dehydrated through graded concentrations of alcohol (50, 70, 95, and 100%). After vacuum drying for a minimum of 2 h, 90 l of hybridization mixture (10 7 cpm/ml) was spotted on each slide, sealed under a coverslip, and incubated at 60°C overnight (ϳ15-20 h) in a slide warmer. Coverslips were then removed and the slides were rinsed in 4ϫ standard saline citrate (SSC) at room temperature. Sections were digested by RNase A (20 g/ml, 37°C, 30 min), rinsed in descending concentrations of SSC (2ϫ, 1ϫ, 0.5ϫ SSC), washed in 0.1ϫ SSC for 30 min at 60°C (1ϫ SSC: 0.15 M NaCl, 15 mM trisodium citrate buffer, pH 7.0), and dehydrated through graded concentrations of alcohol. After being dried for 2 h under vacuum, the sections were exposed at 4°C to X-ray films (Biomax, Kodak, Rochester, N.Y.) for 1-3 days. The slides were defatted in xylene, dipped in NTB-2 nuclear emulsion (Kodak; diluted 1:1 with distilled water), exposed for 7 days (IB␣ transcript), 14 days (CD14 transcript), or 19 days (TLR4 transcript), developed in D19 developer (Kodak) for 3.5 min at 14 -15°C, washed 15 s in water, and fixed in rapid fixer (Kodak) for 5 min. Tissues were then rinsed in running distilled water for 1-2 h, counterstained with thionin (0.25%), dehydrated through graded concentrations of alcohol, cleared in xylene, and coverslipped with distrene plasticizer xylene mounting medium.
Cloning of the full-length rat TLR4 cDNA
Tri-Reagent used for RNA isolation was purchased from Molecular Research Center (Cincinnati, Ohio). Superscript II reverse transcriptase and oligo (dt) primer was purchased from Life Technologies, Inc (Gaithersburg, Md.). Synthetic oligonucleotides were synthesized in our laboratory using an applied Biosystems Model 394 DNA synthesizer (Foster City, Calif.). Pfu DNA polymerase and Robocycler Gradient 40 were purchased from Stratagene Cloning Systems (La Jolla, Calif.). Zero blunt topo PCR cloning kit was purchased from Invitrogen (Carlsbad, Calif.). The Qiagen plasmid kit and Qiaquick PCR purification kit were purchased from Qiagen Inc. (Chatsworth, Calif.). T7 sequencing kit was purchased from USB Corporation (Cleveland, Ohio).
Total RNA was isolated from the rat liver tissue using Tri-Reagent and reverse transcribed into cDNA using Superscript II reverse transcriptase and an oligonucleotide primer with a degenerate 3Ј end of sequence 5Ј-T12 (GAC)N-3Ј. A DNA fragment of 2.5 kb corresponding to the complete coding sequence of the reported rat Toll receptor cDNA (nucleotide 260 to 2767, Genbank accession #AF057025) was amplified by PCR from a cDNA library using a pair of 23 bp oligonucleotide primers complementary to nucleotides 259 to 282 (5Ј-ATGATGCCTCTCTTGCATCTGGC-3Ј) and 2745 to 2767 (5Ј-TCAGGTCAAAGTTGTTGCTTCTT-3Ј). The proofreading polymerase pfu, generating blunt-end extremities, was used to permit direct insertion of the PCR product into the plasmid vector PCR-Blunt II Topo (Zero blunt topo PCR cloning kit, Invitrogen). To confirm the success of the insertion, ϳ130 bp of both PCR product extremities were sequenced using a T7 sequencing kit.
cRNA probe synthesis and preparation
The PCR-Blunt II topo plasmid containing the rat TLR4 cDNA fragment of 2.5 kb was linearized with PstI and KpnI for the antisense and sense riboprobes, respectively. The pBlueScript SK plasmids containing the full-length coding sequence of the rat CD14 cDNA (kindly provided by Dr. Doug Feinstein, Cornell University Medical College, New York; ref 11) or the mouse IB␣ cDNA (kindly provided by Dr. Alain Israël, Institut Pasteur, Paris, France; ref 15) were linearized with SacI and KpnI (CD14) or BamHI and HindIII (IB␣) for the antisense and sense riboprobes, respectively. Radioactive cRNA copies were synthesized by incubation of 250 ng linearized plasmid in 6 mM MgCl 2 , 40 mM Tris (pH 7.9), 2 mM spermidine, 10 mM NaCl, 10 mM dithiothreitol, 0.2 mM ATP/GTP/CTP, 100 Ci of ␣-35 S-UTP (DuPont NEN, #NEG 039H), 20 U RNAsin (Promega, Madison, Wis.), and 10 U of either T7 (CD14 and IB␣ antisense probe, TLR4 sense probe), SP6 (TLR4 antisense probe), or T3 (CD14 and IB␣ sense probe) RNA polymerase for 60 min at 37°C. Unincorporated nucleotides were removed using an ammoniumacetate method: 100 l of DNase solution (1 l DNase, 5 l of 5 mg/ml tRNA, 94 l of 10 mM tris/10 mM MgCl 2 ) was added; 10 min later, a phenol-chloroform extraction was performed. The cRNA was precipitated with 80 l of 5M ammonium acetate and 500 l of 100% ethanol for 20 min on dry ice. The pellet was dried and resuspended in 50 l of 10 mM Tris/1 mM EDTA. A concentration of 10 7 cpm probe was mixed into 1 ml of hybridization solution (500 l formamide, 60 l 5 M NaCl, 10 l 1 M Tris-pH 8.0, 2 l 0.5 M EDTA-pH 8.0, 50 l 20ϫ Denhart's solution, 200 l 50% dextran sulfate, 50 l 10 mg/ml tRNA, 10 l 1M DTT; 118 l Depc water minus volume of probe used). This solution was mixed and heated for 5 min at 65°C before being spotted on slides.
Qualitative analysis
The relative intensity of TLR4 mRNA signal throughout the brain of each animal was assessed on dipped emulsion slides under microscopic evaluation and graded according to the scale of undetectable (Ϫ), low (ϩ), moderate (ϩϩ), strong (ϩϩϩ), or very strong signal (ϩϩϩϩ).
RESULTS
Specificity of the rat TLR4 cRNA probe
The cDNA used in this study to prepare cRNA probes was sequenced and compared with the rat TLR4 cDNA sequence obtained from the Genbank Database, accession #AF057025. The cDNA identity was confirmed by the homology of the coding region from nucleotides 260 to 2767, which exhibited similar sequences. Sense and antisense probes were prepared and in situ hybridization histochemistry was performed on adjacent sections. Figure 1 shows representative examples of hybridized brain sections with either sense (control) and antisense probes. Although a positive hybridization signal can be detected with the antisense probe (right section), the same adjacent sections did not display any positive signal when hybridized with the sense probes (left section). These results provide the evidence of the selectivity of the probes used in this experiment.
Constitutive expression of the gene encoding TLR4 in the rat brain
A low to moderate TLR4 mRNA hybridization signal was found in the CVO organum vasculosum of the lamina terminalis, subfornical organ, median eminence, and the area postrema of vehicle-administered rats (Fig. 2, left column) . The message was quite diffuse across the organs, but also specific inasmuch as adjacent tissues hybridized with the sense probe were completely devoid of positive labeling. Two other groups of nonparenchymal cells also exhibited a moderate to strong hybridization signal for the gene encoding TLR4. Indeed, TLR4-expressing cells were present along the leptomeninges and choroid plexus (chp) of vehicle-injected rats (Fig. 3) . Of interest is the constitutive expression of the LPS receptor mCD14 in the CVOs, chp, and the leptomeninges, a pattern that seemed comparable to that of TLR4 transcript under basal conditions (Figs. 2 and 3) .
Positive TLR4-expressing cells were found in a limited number of parenchymal structures: the posterior hypothalamic nucleus, supramamillary nucleus, cochlear nucleus, and the ventrolateral medulla. A few isolated cells were also detected in the caudal medulla at the level of the gigantocellular and parvicellular reticular nuclei. As shown by Fig. 4 , the pattern of expression suggests that these cells are likely to be neurons, although the possibility remains that a mixed population of cells have the TLR4 biosynthetic machinery in these nuclei. A different type of distribution was observed on emulsion-dipped slides in other parenchymal structures, especially within the regions lining the cerebroventricular system. This signal for TLR4 transcript was characterized by a homogeneous and diffused distribution of silver grains over one or several adjacent brain areas. These include the medial preoptic area (MPOA), paraventricular nucleus of the hypothalamus, dorsomedial hypothalamic nucleus, arcuate nucleus, the ventromedial hypothalamus surrounding the aqueduct and central canal, and the dorsovagal complex. Expression of the gene encoding TLR4 and CD14 in the rat circumventricular organs (CVOs). These darkfield photomicrographs of dipped NTB-2 emulsion slides depict constitutive expression of both transcripts in the organum vasculosum of the lamina terminalis (OVLT), subfornical organ (SFO)/choroid plexus, median eminence (ME), and the area postrema (AP) of rats killed 3 h after i.v. vehicle injection (control). Note that the endotoxin lipopolysaccharide (LPS, at 3 h postinjection) caused a decrease in TLR4 mRNA levels, but an increase in CD14 expression in the CVOs and their adjacent regions (right column; see ref 11 for more details on CD14 expression pattern in the CNS). ϫ25. 
TLR4 and CD14 mRNA in the brain of immunechallenged animals
Systemic LPS treatment caused a robust increase in the CD14 mRNA levels in all the CVOs (11 and Fig. 2, right  column) . The CD14 mRNA signal reached a peak at 3 h postinjection, declined at 6 h, and returned to basal levels 24 h after LPS treatment. CD14-positive cells spread over the anatomical boundaries of these organs in a migratory-like pattern 3 h after i.v. LPS administration (Fig. 6, right column) . At that time, small positive cells were found throughout the entire brain parenchyma, and dual labeling procedure indicated that different cells of myeloid origin have the ability to express CD14 in response to systemic LPS (11) .
The robust increase in CD14 expression in the brain of LPS-treated rats was not associated with a transcriptional activation of the gene encoding TLR4, but a decrease in the relative mRNA levels (Fig. 2) . The hybridization signal was actually barely detectable in the brain of rats that were killed 3 h after being injected with the endotoxin (Table 1) . Although variability occurred among animals, the hybridization signal was generally lower in both parenchymal and nonparenchymal structures of the brain. The message was lower in numerous regions already at 30 min postinjection, although the decrease was apparent in all animals 3 h after the single bolus of LPS. The endotoxin failed to activate the gene encoding TLR4 in any regions of the brain, a phenomenon that contrasts with CD14 expression and NF-B activity. It is interesting to note the robust activation of IB␣ transcript (index of NF-B activity) in the blood vessels and across the brain parenchyma, whereas the TLR4 message essentially vanished in adjacent sections of the MPOA (Fig. 5) .
Circulating IL-1␤ also caused a profound NF-B activity that was associated with a decrease in TLR4 mRNA in the MPOA and other regions surrounding the ventral third ventricle ( Table 2) . Once again, the lower relative levels of TLR4 transcript correlated with the strong expression of the gene encoding IB␣ in the cerebral endothelium and the parenchymal microglia ( Table 2 , Fig. 5 ). As for the LPS treatment, the proinflammatory cytokine failed to activate TLR4 gene in both parenchymal and nonparenchymal structures of the central nervous system (CNS). These darkfield (top and middle panels) and brightfield (bottom panels) photomicrographs of dipped NTB-2 emulsion slides depict positive hybridization signal in the supramamillary nucleus (SUM, left column), cochlear nucleus (CO, middle column), and the lateral reticular formation (LRN) of rats killed 3 h after i.v. injection of sterile saline solution (control). The pattern of expression in these nuclei implicates neurons as the potential cellular source of the TLR4 transcript, although the possibility remains that a mixed population of cells have the TLR4 biosynthetic machinery in these nuclei. Top panels, ϫ10; middle panels, ϫ25; bottom panels, ϫ100.
DISCUSSION
The present study provides evidence that the mRNA encoding TLR4 is present in structures that can be reached by the bloodstream: the CVOs, chp, and leptomeninges. Agglomerations of silver grains forming clear and definite individual cells were found in specific nuclei, although the regions lining the ventral third ventricle exhibited a more diffuse signal. In contrast to the profound transcriptional activation of the LPS receptor CD14 and the indicator of NF-B activity, IB␣, the endotoxin and circulating IL-1␤ caused a significant decrease of TLR4 transcript in most of the constitutively expressing parenchymal and nonparenchymal regions of the brain. Basal expression of CD14 and TLR4 in the CVOs is likely to be a key mechanism in the proinflammatory signal transduction events that originate from these structures during innate immune response. Indeed, cell wall components of the gramnegative bacteria may be selectively recognized by the TLR4/CD14-bearing cells of the CVOs, which allows LPS signaling and then the rapid transcription of proinflammatory cytokines, first within these organs and thereafter across the brain parenchyma during severe endotoxemia.
The rapid induction of IL-1␤, IL-6, and tumor necrosis factor ␣ (TNF-␣) mRNA in the CVOs, chp, and the leptomeninges by systemic LPS treatment clearly indicates that such events occur in these specific populations of cells in the brain (13, 14, 16, 17) . Microscopic analysis of emulsion-dipped slides revealed that TNFpositive cells spread over the anatomical boundaries of the CVOs in a migratory-like pattern during the course of the endotoxemia (14) . A similar pattern of de novo expression was observed for the gene encoding CD14, but not TLR4, in response to circulating LPS. LPSinduced CD14 transcription in parenchymal microglia is dependent on the centrally produced TNF-␣, which actually plays an essential autocrine/paracrine role in triggering parenchymal microglial cells during severe endotoxemia (13). The coexistence of both TLR4 and CD14 receptors in the CVOs may be the recognizing Figure 5 . Systemic inflammatory challenges caused a profound NF-B activation that is associated with a down-regulation of the gene encoding TLR4 in the brain. The mRNA encoding the inhibitory factor IB␣ was not detected under basal condition, whereas i.v. lipopolysaccharide (LPS) and recombinant rat interleukin-1␤ (IL-1␤) injection triggered IB␣ transcription in the cerebral endothelium and microglial cells across the brain parenchyma (left columns; see also refs 15, 19) . The hybridization signal for TLR4 mRNA was barely detectable in these adjacent sections taken at the level of the medial preoptic area (MPOA) 3 h after a single LPS treatment or 30 min after IL-1␤ injection (right columns). Positive TLR4 signal was nevertheless found in the MPOA of vehicle-administered rats (veh, top right panels). Left column of each transcript, ϫ25; right column of each transcript, ϫ100. Figure 6 . Time-related expression of TLR4 and CD14 mRNA in the median eminence (ME) and its surrounding parenchymal structures in response to a single i.v. bolus of lipopolysaccharide (LPS). These darkfield photomicrographs of 30 m brain sections dipped into NTB-2 emulsion milk depict a robust CD14 signal that is localized within the ME 1 h after the LPS challenge (A), but gradually spreads over the anatomical boundaries of the organ at time 3 h postinjection (B). The signal for CD14 mRNA decreased 6 h after the treatment (C, right column), whereas such an expression pattern was not observed for the gene encoding TLR4. As shown by the left column, TLR4 hybridization signal was barely detectable in the ME of endotoxin-challenged rats. Please see ref 11 for more details on CD14 expression pattern in the CNS. ϫ25.
molecules for the endotoxin to trigger the proinflammatory signal transduction events in structures that can be reached from the systemic circulation, whereas subsequent microglial activation in the brain parenchyma is dependent on TNF-␣. Therefore, TLR4 may be essential in this innate immune reaction that originates from the CVOs in response to cell wall components of gram-negative bacteria.
Although a strong increase in CD14 transcription is generally detected after systemic LPS injection, the endotoxin failed to stimulate the gene encoding TLR4. CD14-expressing cells were clearly devoid of TLR4 transcript in microglia across the brain parenchyma during moderate and severe endotoxemia. It is possible that TLR4 is the recognizing molecule for gram-negative bacterial components only in response to systemic infection, whereas CD14 has a more complex role in the proinflammatory signal transduction events in the brain parenchyma. These events may be determinant for orchestrating the neuroinflammatory responses that take place in a well-coordinated manner to activate the resident phagocytic population of cells in the brain. The physiological outcomes of this innate immune response of the CNS likely include a rapid elimination of LPS particles via an increased opsonic activity of the transmembrane CD14 receptor to prevent potential detrimental consequences on neuronal elements during blood sepsis.
Nomura and colleagues have recently reported that TLR4 mRNA expression in mouse peritoneal macrophages significantly decreased within a few hours of LPS treatment and returned to the original level at 24 h (18) . A rapid decrease in surface TLR4 expression was seen as early as 1 h and remained suppressed over 24 h in cells pre-exposed with LPS. These authors suggested that down-regulation of the surface TLR4 expression may be responsible for the decrease in inflammatory cytokine production in tolerant macrophages, which may explain one of the mechanisms for LPS tolerance (18) . These data obtained from systemic macrophages agree completely with the present study, which shows convincing down-regulation of TLR4 gene in response to a single LPS bolus. The phenotype of TLR4 cells in the CVOs was not determined in the present study due to the rather low levels of TLR4 transcript, making interpretation of the agglomeration of silver grains within immunoreactive cells arbitrary. Because LPS has the ability to increase CD14 mRNA in these organs, it was possible to perform the dual labeling for the LPS receptor, and numerous resident macrophages were positive for the transcript (11) . Although both transcripts may not be expressed in the same cells, we speculate here that TLR4 is located at the surface of the phagocytic population of cells of the CVOs, chp, and leptomeninges.
As depicted by different figures, TLR4 transcript levels were low in the cerebral tissue under basal conditions. The signal was nevertheless specific, as we did perform numerous controls to ensure that what was being seen may not be related to an artifact of the in situ hybridization procedure. We had to adjust and maximize the hybridization conditions to detect this transcript in situ by generating the riboprobe just after the prehybridization step on freshly mounted brain sections. This very low level in the brain, however, fits quite well with the fact that the copy number of TLR4 is extremely low in systemic phagocytes compared to the more abundant membrane protein CD14 (8) . It is nevertheless remarkable that so few TLR4 receptors (perhaps 1000 or fewer per cell) residing on macrophages alone have such an important influence in the LPS signaling and the coordination of the biological responses to gram-negative infections (8) . It is expected that CVO TLR4 acts as a sensor for engaging the cerebral innate immune response in the case of invasion during such systemic bacterial infection, which may have detrimental consequences for the neuronal material.
Of interest is the constitutive expression of TLR4 in different nuclei and areas of the brain suggesting a potential role of this membrane-spanning component in the parenchymal elements of the brain. However, TLR4 seems quite specific to cell wall components of gram-negative bacteria; what, then, will a receptor do without ligand? This question obviously is difficult to answer: we are just at the embryonic stage of the mammalian Toll biology, and this is the first report showing evidence that TLR4 may be a key element of the well-organized innate immune response that takes place in the CNS. a ϩϩϩϩ, Very strong signal; ϩϩϩ, strong signal, ϩϩ, moderate signal; ϩ, low but positive signal; Ϫ, undetectable signal for an average of 3 to 5 animals per group and time post-IL-1␤ injection. IB␣ mRNA (bottom line) was evaluated in adjacent coronal sections as an index of NF-B activity, which increased in response to systemic IL-1␤ injection while TLR4 mRNA signal decreased. IL-1␤, intravenous injection of recombinant rat interleukin-1␤ (1.8 g/kg; kindly provided by Dr. R. Hart, The State University of New-Jersey Rutgers, Newark, N.J.); vehicle, 200 l of sterile pyrogen-free saline.
